Article citationsMore>>

J. Hay, B. M. Brady, M. Zitzmann, K. Osmanagaoglu, P. Pollanen and D. Apter, “A Multicenter Phase IIb Study of a Novel Combination of Intramuscular Androgen (Testosterone Decanoate) and Oral Progestogen (Etonogestrel) for Male Hormonal Contraception,” The Journal of Clinical Endocrinology & Metabolism, Vol. 90, No. 4, 2005, pp. 2042-2049. doi:10.1210/jc.2004-0895

has been cited by the following article:

• TITLE: Testosterone and Its Analogs as a Male Contraceptive

  AUTHORS: Abdul S. Ansari, Chandra Shekhar Yadav, Nirmal K. Lohiya

  KEYWORDS: Hormonal Contraception; Suppression of Spermatogenesis; Testosterone; Androgen-Progestin Combination

  JOURNAL NAME: Advances in Sexual Medicine, Vol.3 No.3A, July 19, 2013

  ABSTRACT: Male contraception by means of hormonal approach was initiated more than 60 years ago when men became azoospermic with administration of testosterone. The basic principle of male hormonal contraception is suppression of spermatogenesis. Exogenous testosterone/testosterone analogs alone or in combination with progestin have been tested for contraceptive efficacy by inhibiting gonadotropins release from pituitary gland. In this review article, advancement in different testosterone preparation tested alone or in combination for contraceptive efficacy has been focused. Administration of testosterone or testosterone analogs alone failed to provide uniform azoospermia or severe oligospermia (gestin combination has proved better contraceptive efficacy than testosterone alone. Further, long term studies with hormonal regimens and other alternative approaches are required with fewer side effects for development of safe and reversible contraceptive.